Retatrutide is a new treatment in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By activating these receptors, https://carlyoboh092967.luwebs.com/36969217/setmelanotide-a-promising-new-treatment-for-obesity